Prehabilitation in Gynaecological Cancer Patients
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Prehabilitation refers to interventions aiming to improve patients' resilience and functional capacity before a known stressful event, e.g., scheduled surgery. These interventions usually consist of physical activity and psychological and nutritional support. There is substantial evidence of the positive effect of multimodal prehabilitation among patients treated surgically for non-gynaecological cancers; however, no prospective data are available in gynaecological cancer patients. PHOCUS trial is a prospective randomised trial aiming to evaluate the role of multimodal prehabilitation in patients with gynaecological cancer. Sixty-four patients will be randomised in single institution within 36 months with a 1:1 ratio into ARM A: control arm which will be provided with a basic information and standard of care support; ARM B: active arm undergoing multimodal prehabilitation composed of physical activity and psychological and nutritional support. All patients will be assessed at standard intervals (three times during the trial) by a spectrum of non-invasive tests, evaluating physical functional capacity, postoperative morbidity, nutritional status, level of stress and anxiety, and quality of life.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjentki z rakiem jajnika, które nie kwalifikują się do operacji od razu, ale są leczone chemioterapią i będą operowane później.
- •Pacjentki z wczesnym rakiem macicy (stopień I lub II), które są uważane za osłabione i kwalifikują się do leczenia hormonalnego.
✗ Disqualifies
- •Pacjentki, które mają inny nowotwór w trakcie leczenia.
- •Pacjentki, których leczenia nie można odłożyć.
- •Pacjentki, które nie mogą uczestniczyć w programie przygotowawczym lub nie są w stanie chodzić.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 85 Years
- Last updated (source)
- September 28, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Gynecologic Oncology Center in Prague
Prague, Czechia
Trial contact
Jana Stribrna
Stefan Lednicky, MD.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/29/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.